Matthew N. Brams
Child and Adolescent Psychiatry
17225 El Camino Real Ste 210
Houston, TX 77058
Houston, TX 77058
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy and Safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results From a Phase 3, Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial.
Journal: Journal of child and adolescent psychopharmacology
Published: July 22, 2026
Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study.
Journal: Frontiers in psychiatry
Published: October 09, 2023
Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study.
Journal: Journal of child and adolescent psychopharmacology
Published: February 22, 2023
Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia.
Journal: The Journal of clinical psychiatry
Published: November 30, 2022
A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: October 29, 2021
Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations.
Journal: Neuropsychiatric disease and treatment
Published: March 11, 2021
Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study.
Journal: Journal of child and adolescent psychopharmacology
Published: October 22, 2020
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.
Journal: Journal of child and adolescent psychopharmacology
Published: August 30, 2019
A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design.
Journal: Postgraduate medicine
Published: May 29, 2018
Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
Journal: Journal of child and adolescent psychopharmacology
Published: December 07, 2017
SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.
Journal: Journal of child and adolescent psychopharmacology
Published: August 18, 2017
Last Updated: 09/26/2026